Epidemiology of extra-pulmonary tuberculosis in Israel, 1999-2010

Int J Tuberc Lung Dis. 2013 Feb;17(2):229-33. doi: 10.5588/ijtld.12.0375.

Abstract

Setting: The Israeli national tuberculosis (TB) surveillance system.

Objectives: To describe the epidemiology of extra-pulmonary tuberculosis (EPTB) in Israel between 1999 and 2010 and identify more susceptible populations.

Design: Data were retrieved from the National Tuberculosis Registry and the Israeli Bureau of Statistics.

Results: During the study period, 995 EPTB patients were notified, corresponding to 19.6% of all TB cases. The average annual male:female ratio was 0.8, and the human immunodeficiency virus (HIV) infection rate was 5%. Most EPTB affected the lymph nodes (39.8%), pleura (16.9%) and urinary system (11.1%). Most EPTB patients (81.8%) were non-Israeli born. The estimated average annual incidence in Israeli-born citizens, non-Israeli-born citizens and migrant workers was respectively 0.23, 2.2 and 7.5 per 100,000 population. The ratio of non-Israeli-born migrant workers to non-Israeli-born citizens with EPTB decreased from 1:6.3 in 1999 to 1:0.78 in 2010. Culture results were obtained for 624 (62.9%) of all cases. Of these, 41 (6.6%) were resistant to at least one first-line anti-tuberculosis drug and 8 (1.3%) were multidrug-resistant. Treatment success was achieved in 86.5%.

Conclusions: Physicians should be aware of the possibility of EPTB in older patients, especially in the non-Israeli-born. Innovative screening procedures should be implemented for migrants from high-burden countries.

Publication types

  • Comparative Study

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Female
  • Humans
  • Incidence
  • Israel / epidemiology
  • Male
  • Mass Screening*
  • Registries*
  • Retrospective Studies
  • Survival Rate / trends
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology*
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology*

Substances

  • Antitubercular Agents